LISBON (MedPage Today) -- The diabetes medication vildagliptin may be beneficial in patients with type 2 diabetes and heart failure, but its cardiovascular safety is uncertain, a placebo-controlled trial showed. via MedPageToday.com - medical news plus CME for physicians Read More Here..
No comments:
Post a Comment